Intelligent Patient-Controlled Liquid Oral Medicine Dispenser and Deactivation System
Legal Citation
Summary of the Inventive Concept
A synergistic system integrating a patient-controlled liquid oral medicine dispenser and deactivation system with AI, IoT, blockchain, and nanomaterial technologies to provide secure, personalized, and adaptive medication management.
Background and Problem Solved
The original patent addressed the limitations of invasive patient-controlled medication administration methods, including complexity, infection risks, and diversion potential. The new inventive concept builds upon this foundation by incorporating advanced technologies to overcome the remaining challenges, such as medication adherence, diversion prevention, and real-time monitoring.
Detailed Description of the Inventive Concept
The intelligent system comprises a patient-controlled liquid oral medicine dispenser and deactivation system integrated with an AI-powered medication management platform, IoT sensors, a blockchain-based ledger, and a nanomaterial-based sensor. The AI platform monitors and adapts to patient behavior to optimize medication dosing and prevent diversion. IoT sensors track medication usage patterns and transmit data to a remote server for analysis and feedback. The blockchain-based ledger records and verifies medication administration events, ensuring tamper-proof tracking. The nanomaterial-based sensor detects and responds to medication tampering or diversion attempts. The system can be implemented in various forms, including wearable devices and smart medication containers, to provide personalized medication recommendations and alerts.
Novelty and Inventive Step
The new claims introduce the novel combination of AI, IoT, blockchain, and nanomaterial technologies with the patient-controlled liquid oral medicine dispenser and deactivation system, providing a synergistic solution that addresses the limitations of the original patent. The inventive step lies in the integration of these distinct technologies to create a more powerful, secure, and adaptive medication management system.
Alternative Embodiments and Variations
Alternative embodiments may include integrating the system with electronic health records, using machine learning algorithms to predict patient behavior, or incorporating additional sensors to monitor medication efficacy. Variations may include using different AI platforms, IoT protocols, or blockchain architectures to achieve the same synergistic effect.
Potential Commercial Applications and Market
The intelligent patient-controlled liquid oral medicine dispenser and deactivation system has significant commercial potential in the healthcare industry, particularly in the areas of medication management, patient safety, and personalized medicine. Target markets may include hospitals, clinics, pharmacies, and healthcare technology companies.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61J7/0053 |
| A | A61 | A61J1/22 |
| G | G16 | G16H20/13 |
| A | A61 | A61J2200/30 |
| A | A61 | A61J2200/70 |
Original Patent Information
| Patent Number | US 11,857,504 |
|---|---|
| Title | Patient-controlled liquid oral medicine dispenser and deactivation system |
| Assignee(s) | Yale University |